186 related articles for article (PubMed ID: 28576058)
41. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies.
Petri-Fink A; Steitz B; Finka A; Salaklang J; Hofmann H
Eur J Pharm Biopharm; 2008 Jan; 68(1):129-37. PubMed ID: 17881203
[TBL] [Abstract][Full Text] [Related]
42. Fabrication of contrast agents for magnetic resonance imaging from polymer-brush-afforded iron oxide magnetic nanoparticles prepared by surface-initiated living radical polymerization.
Ohno K; Mori C; Akashi T; Yoshida S; Tago Y; Tsujii Y; Tabata Y
Biomacromolecules; 2013 Oct; 14(10):3453-62. PubMed ID: 23957585
[TBL] [Abstract][Full Text] [Related]
43. The effect of nanocrystalline silicon host on magnetic properties of encapsulated iron oxide nanoparticles.
Granitzer P; Rumpf K; Gonzalez-Rodriguez R; Coffer JL; Reissner M
Nanoscale; 2015 Dec; 7(47):20220-6. PubMed ID: 26575478
[TBL] [Abstract][Full Text] [Related]
44. Two-dimensional magnetic WS2@Fe3O4 nanocomposite with mesoporous silica coating for drug delivery and imaging-guided therapy of cancer.
Yang G; Gong H; Liu T; Sun X; Cheng L; Liu Z
Biomaterials; 2015 Aug; 60():62-71. PubMed ID: 25985153
[TBL] [Abstract][Full Text] [Related]
45. Magnetic iron oxide nanoparticles for tumor-targeted therapy.
Chen B; Wu W; Wang X
Curr Cancer Drug Targets; 2011 Feb; 11(2):184-9. PubMed ID: 21158723
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
[TBL] [Abstract][Full Text] [Related]
47. Increasing DNA binding affinity of doxorubicin by loading on Fe
Mirzaei-Kalar Z; Yavari A; Jouyban A
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Mar; 229():117985. PubMed ID: 31901801
[TBL] [Abstract][Full Text] [Related]
48. Daunomycin-loaded superparamagnetic iron oxide nanoparticles: Preparation, magnetic targeting, cell cytotoxicity, and protein delivery research.
Liu MC; Jin SF; Zheng M; Wang Y; Zhao PL; Tang DT; Chen J; Lin JQ; Wang XH; Zhao P
J Biomater Appl; 2016 Aug; 31(2):261-72. PubMed ID: 27288463
[TBL] [Abstract][Full Text] [Related]
49. Luteinizing hormone-releasing hormone targeted superparamagnetic gold nanoshells for a combination therapy of hyperthermia and controlled drug delivery.
Mohammad F; Al-Lohedan HA
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():692-700. PubMed ID: 28482580
[TBL] [Abstract][Full Text] [Related]
50. [Preparation and in vitro evaluation of doxorubicin-loaded magnetic iron oxide nanoparticles].
Shen S; Wu L; Wang CR; Qi XY; Ge YR; Jin Y
Yao Xue Xue Bao; 2013 Dec; 48(12):1844-9. PubMed ID: 24689244
[TBL] [Abstract][Full Text] [Related]
51. Development of carbonyl iron/ethylcellulose core/shell nanoparticles for biomedical applications.
Arias JL; López-Viota M; Ruiz MA; López-Viota J; Delgado AV
Int J Pharm; 2007 Jul; 339(1-2):237-45. PubMed ID: 17398048
[TBL] [Abstract][Full Text] [Related]
52. Chitosan-coated superparamagnetic iron oxide nanoparticles for doxorubicin delivery: synthesis and anticancer effect against human ovarian cancer cells.
Javid A; Ahmadian S; Saboury AA; Kalantar SM; Rezaei-Zarchi S
Chem Biol Drug Des; 2013 Sep; 82(3):296-306. PubMed ID: 23594157
[TBL] [Abstract][Full Text] [Related]
53. Targeted delivery of doxorubicin into tumor cells via MMP-sensitive PEG hydrogel-coated magnetic iron oxide nanoparticles (MIONPs).
Nazli C; Demirer GS; Yar Y; Acar HY; Kizilel S
Colloids Surf B Biointerfaces; 2014 Oct; 122():674-683. PubMed ID: 25183059
[TBL] [Abstract][Full Text] [Related]
54. Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study.
Gaihre B; Khil MS; Lee DR; Kim HY
Int J Pharm; 2009 Jan; 365(1-2):180-9. PubMed ID: 18790029
[TBL] [Abstract][Full Text] [Related]
55. IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy.
Fu X; Wang X; Zhou S; Zhang Y
Int J Nanomedicine; 2017; 12():3751-3766. PubMed ID: 28553112
[TBL] [Abstract][Full Text] [Related]
56. AN in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain.
Akilo OD; Choonara YE; Strydom AM; du Toit LC; Kumar P; Modi G; Pillay V
Int J Pharm; 2016 Mar; 500(1-2):196-209. PubMed ID: 26806465
[TBL] [Abstract][Full Text] [Related]
57. Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles.
Yu MK; Kim D; Lee IH; So JS; Jeong YY; Jon S
Small; 2011 Aug; 7(15):2241-9. PubMed ID: 21648076
[TBL] [Abstract][Full Text] [Related]
58. Multifunctional superparamagnetic iron oxide nanoparticles for combined chemotherapy and hyperthermia cancer treatment.
Quinto CA; Mohindra P; Tong S; Bao G
Nanoscale; 2015 Aug; 7(29):12728-36. PubMed ID: 26154916
[TBL] [Abstract][Full Text] [Related]
59. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
[TBL] [Abstract][Full Text] [Related]
60. Thermo-responsive magnetic Fe
Jamal Al Dine E; Ferjaoui Z; Ghanbaja J; Roques-Carmes T; Meftah A; Hamieh T; Toufaily J; Schneider R; Marchal S; Gaffet E; Alem H
Int J Pharm; 2017 Nov; 532(2):738-747. PubMed ID: 28893585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
